Chemomab Therapeutics (CMMB)
(Real Time Quote from BATS)
$1.20 USD
-0.09 (-6.98%)
Updated Jun 6, 2024 03:14 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Brokerage Reports
Chemomab Therapeutics Ltd. Sponsored ADR [CMMB]
Reports for Purchase
Showing records 1 - 8 ( 8 total )
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
PSC Ph 2 Enrollment Completes Early Accelerating Top-line Results to Mid-Year
Provider: Roth Capital Partners, Inc.
Analyst: WHITE J
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Resuming Coverage with a Buy and $7 PT
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Biotechnology -Healthcare Coverage Update
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
Company: Chemomab Therapeutics Ltd. Sponsored ADR
Industry: Medical - Biomedical and Genetics
|